| 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ... Annals of the rheumatic diseases 78 (6), 736-745, 2019 | 1999 | 2019 |
| Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of … GK Bertsias, M Tektonidou, Z Amoura, M Aringer, I Bajema, JHM Berden, ... Annals of the rheumatic diseases 71 (11), 1771-1782, 2012 | 1270 | 2012 |
| EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including … GK Bertsias, JPA Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, ... Annals of the rheumatic diseases 67 (2), 195-205, 2008 | 1055 | 2008 |
| 2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the … A Fanouriakis, M Kostopoulou, K Cheema, HJ Anders, M Aringer, ... Annals of the rheumatic diseases 79 (6), 713-723, 2020 | 797 | 2020 |
| Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis Y Wu, B Levis, KE Riehm, N Saadat, AW Levis, M Azar, DB Rice, J Boruff, ... Psychological medicine 50 (8), 1368-1380, 2020 | 320 | 2020 |
| EULAR recommendations for the management of systemic lupus erythematosus: 2023 update A Fanouriakis, M Kostopoulou, J Andersen, M Aringer, L Arnaud, SC Bae, ... Annals of the rheumatic diseases 83 (1), 15-29, 2024 | 310 | 2024 |
| Rituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future PP Sfikakis, JN Boletis, GC Tsokos Current opinion in rheumatology 17 (5), 550-557, 2005 | 243 | 2005 |
| Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis PP Sfikakis, VL Souliotis, KG Fragiadaki, HM Moutsopoulos, JN Boletis, ... Clinical immunology 123 (1), 66-73, 2007 | 241 | 2007 |
| Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis JN Boletis, JPA Ioannidis, KA Boki, HM Moutsopoulos The Lancet 354 (9178), 569-570, 1999 | 199 | 1999 |
| An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for … E Frangou, D Vassilopoulos, J Boletis, DT Boumpas Autoimmunity reviews 18 (8), 751-760, 2019 | 155 | 2019 |
| Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the … J Barratt, R Lafayette, J Kristensen, A Stone, D Cattran, J Floege, V Tesar, ... Kidney international 103 (2), 391-402, 2023 | 150 | 2023 |
| Lupus nephritis: treatment with mycophenolate mofetil PP Kapitsinou, JN Boletis, FN Skopouli, KA Boki, HM Moutsopoulos Rheumatology 43 (3), 377-380, 2004 | 132 | 2004 |
| Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients S Marinaki, S Adamopoulos, D Degiannis, S Roussos, ID Pavlopoulou, ... American Journal of Transplantation 21 (8), 2913-2915, 2021 | 126 | 2021 |
| The accuracy of the Patient Health Questionnaire-9 algorithm for screening to detect major depression: an individual participant data meta-analysis C He, B Levis, KE Riehm, N Saadat, AW Levis, M Azar, DB Rice, ... Psychotherapy and psychosomatics 89 (1), 25-37, 2020 | 123 | 2020 |
| Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype‐specific incidence and molecular characterization of genotype 4 isolates A Katsoulidou, V Sypsa, NC Tassopoulos, J Boletis, A Karafoulidou, ... Journal of viral hepatitis 13 (1), 19-27, 2006 | 119 | 2006 |
| Balkan nephropathy: evolution of our knowledge G Bamias, J Boletis American Journal of Kidney Diseases 52 (3), 606-616, 2008 | 118 | 2008 |
| Long‐term follow up for anti‐HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules ISA Ntokou, AG Iniotaki, EN Kontou, MN Darema, MD Apostolaki, ... Transplant international 24 (11), 1084-1093, 2011 | 108 | 2011 |
| Everolimus (Certican) in renal transplantation: a review of clinical trial data, current usage, and future directions J Pascual, IN Boletis, JM Campistol Transplantation reviews 20 (1), 1-18, 2006 | 102 | 2006 |
| Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study JN Boletis, S Marinaki, C Skalioti, SS Lionaki, A Iniotaki, PP Sfikakis Nephrology Dialysis Transplantation 24 (7), 2157-2160, 2009 | 101 | 2009 |
| Urgent superselective segmental renal artery embolization in the treatment of life-threatening renal hemorrhage P Pappas, P Leonardou, S Papadoukakis, G Zavos, S Michail, J Boletis, ... Urologia Internationalis 77 (1), 34-41, 2006 | 100 | 2006 |
